Clinical Trial Update: Application of Lactobacillus Salivarius CECT5713 in Infertility of Unknown Origin [Phase 2]

View source ↗

Summary

Phase 2 trial investigating Lactobacillus salivarius CECT5713 for infertility of unknown origin has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abortion in First Trimester
• Infertility of Unknown Origin
• Spontaneous Abortion

Drugs mentioned

• Lactobacillus salivarius CECT5713 (Lactobacillus salivarius CECT5713)

Snippet

Sponsor: Universidad Complutense de Madrid | Conditions: Abortion, Spontaneous, Abortion in First Trimester | Phase 2 | Status: COMPLETED